23 / 42
Unmet medical need remains: combination therapies
are likely to be requiro improve patient outcomes
Targeted therapy
Immune checkpoint
monotherapy
Chemotherapy
Hypothetical KM curve
Time
Percent survival
Combinations with
immunotherapy